Skip to main content
Browse by:

The Investigational New Drug (IND) Workshop

Event Image
Icon calendar
Tuesday, April 10, 2018
Icon time
1:00 pm - 4:00 pm
Icon speaker
Daniel Tonkin, PhD, RAC & Stephanie Pierce, PhD, RAC

Define an investigational drug, including off-label use of FDA approved drugs

Provide guidance on determining when the IND regulations apply to research studies.

Discuss the preparation and submission of IND applications to FDA

Review maintenance and safety reporting requirements

Encourage participant discussion of case scenarios

Contact: Susan Nagorski